Human leukocyte antigen (HLA) class I defects in head and neck cancer: molecular mechanisms and clinical significance (Q36290298)

13 August 2017

1 reference

title

Human leukocyte antigen (HLA) class I defects in head and neck cancer: molecular mechanisms and clinical significance (English)

1 reference

13 August 2017

1 reference

1 reference

head and neck carcinoma

1 reference

3

Soldano Ferrone

1 reference

13 August 2017

1

Robert L Ferris

1 reference

13 August 2017

Jennifer L Hunt

2

1 reference

13 August 2017

1 January 2005

1 reference

13 August 2017

1 reference

13 August 2017

33

1 reference

13 August 2017

113-133

1 reference

13 August 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1385/ir:33:2:113

13 August 2017

0 references

cites work

Diagnostic assessment of laryngeal cancer

1 reference

12 December 2020

A fresh look at tumor immunosurveillance and immunotherapy.

1 reference

12 December 2020

A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter.

1 reference

12 December 2020

Increased aberrance of cytokine expression in plasma of patients with more advanced squamous cell carcinoma of the head and neck.

1 reference

12 December 2020

A critical role for tapasin in the assembly and function of multimeric MHC class I-TAP complexes

1 reference

12 December 2020

HLA class I alterations in head and neck squamous cell carcinoma

1 reference

12 December 2020

Immune system versus tumor: shifting the balance in favor of DCs and effective immunity

1 reference

12 December 2020

Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance.

1 reference

12 December 2020

Antigen processing defects in cervical carcinomas limit the presentation of a CTL epitope from human papillomavirus 16 E6.

1 reference

12 December 2020

Estimates of the worldwide frequency of sixteen major cancers in 1980

1 reference

12 December 2020

Antigen processing and recognition

1 reference

12 December 2020

Second malignant neoplasms in patients successfully treated with multimodality treatment for advanced head and neck cancer

1 reference

12 December 2020

Real-time quantitative PCR demonstrates low prevalence of human papillomavirus type 16 in premalignant and malignant lesions of the oral cavity

1 reference

12 December 2020

Beta 2-microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptide

1 reference

12 December 2020

Progress in head and neck cancer immunotherapy: can tolerance and immune suppression be reversed?

1 reference

12 December 2020

Molecular mechanisms of loss of beta 2-microglobulin expression in drug-resistant breast cancer sublines and its involvement in drug resistance

1 reference

12 December 2020

Characterization of human lymphocyte antigen class I antigen-processing machinery defects in renal cell carcinoma lesions with special emphasis on transporter-associated with antigen-processing down-regulation

1 reference

12 December 2020

Association of tapasin and HLA class I antigen down-regulation in primary maxillary sinus squamous cell carcinoma lesions with reduced survival of patients

1 reference

12 December 2020

High frequency of functionally active Melan-a-specific T cells in a patient with progressive immunoproteasome-deficient melanoma

1 reference

12 December 2020

Histocompatibility antigens in primary and metastatic squamous cell carcinoma of the larynx

1 reference

12 December 2020

MHC class I antigens, immune surveillance, and tumor immune escape.

1 reference

12 December 2020

Combination surgery and nonviral interleukin 2 gene therapy for head and neck cancer

1 reference

12 December 2020

Assignment of the major histocompatibility complex to a region of the short arm of human chromosome 6

1 reference

12 December 2020

Methylation-regulated expression of HLA class I antigens in melanoma

1 reference

12 December 2020

Endoplasmic reticulum chaperone‐specific monoclonal antibodies for flow cytometry and immunohistochemical staining

1 reference

12 December 2020

DNA hypermethylation is a mechanism for loss of expression of the HLA class I genes in human esophageal squamous cell carcinomas

1 reference

12 December 2020

Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP

1 reference

12 December 2020

HLA-G in melanoma: can the current controversies be solved?

1 reference

12 December 2020

High expression of HLA-A2 on an oral squamous cell carcinoma with down-regulated transporter for antigen presentation

1 reference

12 December 2020

Tumor-induced death of immune cells: its mechanisms and consequences

1 reference

12 December 2020

Selective loss of human leukocyte class I allospecificities and staining of melanoma cells by monoclonal antibodies recognizing monomorphic determinants of class I human leukocyte antigens.

1 reference

12 December 2020

Report of a clinical trial in 12 patients with head and neck cancer treated intratumorally and peritumorally with multikine

1 reference

12 December 2020

Dynamics of Cell Surface Molecules During T Cell Recognition

1 reference

12 December 2020

Antigen processing and recognition

1 reference

12 December 2020

Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: β2‐microglobulin inactivation in MSI‐positive tumors and LMP7/TAP2 downregulation in MSI‐negative tumors

1 reference

12 December 2020

MHC-restricted recognition of autologous melanoma by tumor-specific cytotoxic T cells. Evidence for restriction by a dominant HLA-A allele

1 reference

12 December 2020

Role of gangliosides in tumour progression: a molecular target for cancer therapy?

1 reference

12 December 2020

Analysis of glycosphingolipids of human head and neck carcinomas with comparison to normal tissue

1 reference

12 December 2020

Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report

1 reference

12 December 2020

Microsatellite analysis of microdissected tumor cells and 6p high density microsatellite analysis in head and neck squamous cell carcinomas with down-regulated human leukocyte antigen class I expression

1 reference

12 December 2020

HLA class I expression and chromosomal deletions at 6p and 15q in head and neck squamous cell carcinomas

1 reference

12 December 2020

Modified flow cytometry and cell-ELISA methodology to detect HLA class I antigen processing machinery components in cytoplasm and endoplasmic reticulum.

1 reference

12 December 2020

Trimming of antigenic peptides in an early secretory compartment

1 reference

12 December 2020

HLA class I and class II antigen expression on squamous cell carcinoma of the head and neck

1 reference

12 December 2020

Lysis of human melanoma cells by autologous cytolytic T cell clones. Identification of human histocompatibility leukocyte antigen A2 as a restriction element for three different antigens

1 reference

12 December 2020

The beta2-microglobulin gene is on chromosome 15 and not in the HL-A region

1 reference

12 December 2020

A listing of human tumor antigens recognized by T cells: March 2004 update

1 reference

12 December 2020

Rexpression of HLA class I antigens and restoration of antigen-specific CTL response in melanoma cells following 5-aza-2'-deoxycytidine treatment

1 reference

12 December 2020

Multiple mechanisms generate HLA class I altered phenotypes in laryngeal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21

1 reference

12 December 2020

Adjuvant therapy in head and neck cancer

1 reference

12 December 2020

Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines

1 reference

12 December 2020

Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome

1 reference

12 December 2020

Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis

1 reference

12 December 2020

Failure at distant sites following multimodality treatment for advanced head and neck cancer

1 reference

12 December 2020

HLA-A- and HLA-B-specific monoclonal antibodies reactive with free heavy chains in western blots, in formalin-fixed, paraffin-embedded tissue sections and in cryo-immuno-electron microscopy

1 reference

12 December 2020

Human leukocyte antigen class I allelic and haplotype loss in squamous cell carcinoma of the head and neck: clinical and immunogenetic consequences

1 reference

12 December 2020

Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance

1 reference

12 December 2020

High frequency of altered HLA class I phenotypes in laryngeal carcinomas

1 reference

12 December 2020

Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity

1 reference

12 December 2020

An immunohistochemical study of altered immunomodulatory molecule expression in head and neck squamous cell carcinoma

1 reference

12 December 2020

HLA antigen expression in routinely processed head and neck squamous cell carcinoma primary lesions of different sites

1 reference

12 December 2020

Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma

1 reference

12 December 2020

Prevalent expression of the immunostimulatory MHC class I chain-related molecule is counteracted by shedding in prostate cancer

1 reference

12 December 2020

The effect of the interferon-gamma-inducible processing machinery on the generation of a naturally tumor-associated human cytotoxic T lymphocyte epitope within a wild-type and mutant p53 sequence context

1 reference

12 December 2020

Combination immunotherapy of squamous cell carcinoma of the head and neck: a phase 2 trial

1 reference

12 December 2020

Combination nonviral cytokine gene therapy for head and neck cancer

1 reference

12 December 2020

Proteolysis, proteasomes and antigen presentation

1 reference

12 December 2020

Role of antiapoptotic proteins in tumor necrosis factor-related apoptosis-inducing ligand and cisplatin-augmented apoptosis

1 reference

12 December 2020

Mutation in the beta 2m gene is not a frequent event in head and neck squamous cell carcinomas

1 reference

12 December 2020

The dendritic cell and human cancer vaccines

1 reference

12 December 2020

Lack of MHC class I antigens and tumour aggressiveness of the squamous cell carcinoma of the larynx

1 reference

12 December 2020

A class I antigen, HLA-G, expressed in human trophoblasts

1 reference

12 December 2020

Selective histocompatibility leukocyte antigen (HLA)-A2 loss caused by aberrant pre-mRNA splicing in 624MEL28 melanoma cells

1 reference

12 December 2020

Characterization of antigen processing machinery and Survivin expression in tonsillar squamous cell carcinoma

1 reference

12 December 2020

Coordinated downregulation of the antigen presentation machinery and HLA class I/beta2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer

1 reference

12 December 2020

ER aminopeptidases generate a unique pool of peptides for MHC class I molecules.

1 reference

12 December 2020

Tumor aggressiveness and MHC class I and II antigens in laryngeal and breast cancer.

1 reference

12 December 2020

Peptide-based vaccines for cancer immunotherapy

1 reference

12 December 2020

Cancer statistics, 2001

1 reference

12 December 2020

Identifiers

DOI

10.1385/IR:33:2:113

1 reference

PubMed ID

16234579

Dimensions Publication ID

13 August 2017

0 references

1 reference

PubMed ID

16234579